Welcome to our dedicated page for BlackRock SEC filings (Ticker: BLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BlackRock, Inc. filings document the regulatory record of an asset manager with NYSE-listed common stock and 3.750% notes due 2035. Form 8-K disclosures furnish earnings releases and Regulation FD materials, report results of operations, and record material agreements such as amendments to the company's revolving credit facility.
Proxy and governance filings cover board elections, director independence, executive compensation, pay-versus-performance data and shareholder voting matters. Other 8-K disclosures describe compensation arrangements linked to BlackRock's private markets investment funds, capital-structure information for registered securities, and governance actions affecting the board and senior executive incentive programs.
BlackRock, Inc. insider activity: President and Director Robert Kapito reported a disposition of 1,000 shares of BlackRock common stock on 11/13/2025, coded as a "G" transaction, which typically indicates a gift, at a reported price of $0 per share. Following this transaction, he beneficially owned 209,324.4 shares of BlackRock common stock, including restricted stock units that vest over 1 to 3 years and are settled in an equal number of common shares. No derivative securities transactions were reported in this filing.
BlackRock, Inc. filed a Form 13F-HR combination report, indicating some holdings are reported here and others by additional managers. The filing lists a Form 13F Information Table Entry Total of 49,030 and a Form 13F Information Table Value Total of $5,712,254,484,794 (round to the nearest dollar). Number of Other Included Managers: 30.
BlackRock states it is the parent holding company of various investment managers and disclaims investment discretion at the parent level; the report aggregates information on behalf of its subsidiaries where required. The report was signed by /s/ Spencer Fleming, Attorney-In-Fact, in New York, NY.
BlackRock, Inc. reported Q3 2025 results with total revenue of $6,509 million versus $5,197 million a year ago, driven by higher investment advisory, administration and securities lending revenue of $5,046 million and technology services and subscription revenue of $515 million. Operating income was $1,955 million compared with $2,006 million in the prior‑year quarter.
Net income attributable to BlackRock was $1,323 million versus $1,631 million, and diluted EPS was $8.43 versus $10.90. The Company completed the HPS Investment Partners acquisition on July 1, 2025, largely paid in Subco Units, which lifted goodwill to $35,356 million from $25,949 million and intangible assets to $28,162 million from $20,743 million. Contingent consideration liabilities increased to $7,978 million, and redeemable noncontrolling interests related to Subco were $2,904 million.
Cash and cash equivalents were $9,979 million and investments were $13,669 million as of September 30, 2025. Shares outstanding were 155,150,909 as of October 31, 2025; fully diluted shares were 163,138,922, including 7,988,013 exchangeable Subco Units.
BlackRock, Inc. (BLK) reported insider activity: a Senior Managing Director filed a Form 4 for multiple open-market sales of Common Stock on 10/20/2025. Reported weighted average sale prices ranged from about $1,160 to $1,170 per share across separate trades disclosed with exact price ranges.
Examples include 1,700 shares at a weighted average price of $1,160.2205 and 1,096 shares at $1,169.907. Following the final reported transaction, the insider beneficially owned 7,205 shares. The filing notes these holdings include Common Stock and Restricted Stock Units that vest over 1 to 3 years, with each RSU payable in an equal number of shares.
BlackRock (BLK) reported a Form 144 notice covering a proposed sale of 12,000 shares of common stock, reflecting an aggregate market value of $13,980,505.92. The filing lists Merrill Lynch, Pierce, Fenner & Smith Inc. as broker, an approximate sale date of 10/20/2025, and the NYSE as the exchange.
Shares outstanding were reported as 154,853,337. In the prior three months, Rachel Lord sold 18,036 shares on 07/25/2025 for $20,301,296.40. The securities to be sold were acquired via vesting from the issuer on 01/31/2022 (3,726 shares), 01/31/2023 (6,240 shares), and 01/31/2024 (2,034 shares).
BlackRock, Inc. (BLK) reported its quarterly results for the three and nine months ended September 30, 2025, and furnished related materials. The company issued an earnings release and scheduled an investor conference call and webcast to discuss the results.
The filing includes the earnings release (Exhibit 99.1) and a Third Quarter 2025 Earnings Supplement (Exhibit 99.2). These materials provide detail on recent performance and will be discussed on the company’s investor call on October 14, 2025.
Kathleen Murphy, a director of BlackRock, Inc. (BLK), reported non‑derivative transactions consisting of a grant of 256 restricted stock units on 05/15/2025 and an award of 30 shares on 09/30/2025. The 256 RSUs were valued using the average price of $978.275 per share and vest upon re‑election at the 2026 Annual Meeting; they will be settled in shares on the third anniversary of the grant unless an earlier settlement election is made upon departure from the board. The 30 shares were based on the closing price of $1,165.87 on 09/30/2025. Following the reported transactions, Ms. Murphy directly beneficially owned 446 shares and held additional indirect interests through family trusts and a trust for her son totaling 68 shares.
Charles H. Robbins, a director of BlackRock, Inc. (BLK), was granted 2,820 shares of common stock on 09/30/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant was valued using the closing stock price of $1,165.87 per share on that date and was reported on Form 4 with a filing signature dated 10/02/2025. The Form indicates the shares were issued to a nonemployee director and the filing was made by one reporting person through an attorney-in-fact.
Kristin C. Peck, a Director of BlackRock, Inc. (BLK), was granted 1,750 shares of common stock on 09/30/2025 under the companys Third Amended and Restated 1999 Stock Award and Incentive Plan. The grant was valued using the closing share price of $1,165.87 on the grant date, and the transaction is reported as a non-derivative acquisition. The Form 4 lists the ownership following the reported transaction as 1,750 shares held directly. The filing was signed by an attorney-in-fact on 10/02/2025.
Gordon M. Nixon, a director of BlackRock, Inc. (BLK), was granted 31 shares of common stock on 09/30/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant was valued using the closing price of $1,165.87 per share on that date and was recorded at a price of $0 for the reporting transaction (a director award). After the grant, Mr. Nixon beneficially owned 5,275 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025.